Biologically Active Peptides
- Home
- Catalog peptides
- Biologically Active Peptides
Showing 1009–1044 of 1047 results
Nombre
Catalogue
Target
Category
Subcategory
-
Peptide name
Catalogue
PPH08-1045Target
Substrate for Plasma Kallikrein, Cathespin B/L, and Arg-GingipainCategory
-
Peptide name
Catalogue
PPH08-1046Target
Substrate for MetalloproteinaseCategory
-
Peptide name
Catalogue
PPH08-0133Target
a-synuclein has been suggested to be implicated in the pathogenesis of Parkinson’s disease and related neurodegenerative disorders, and more recently, to be an important regulatory component of vesicular transport in neuronal cells. Moreover, recent studiCategory
-
Peptide name
Catalogue
PPH08-0131Target
. a-synuclein has been suggested to be implicated in the pathogenesis of Parkinson’s disease and related neurodegenerative disorders, and more recently, to be an important regulatory component of vesicular transport in neuronal cells. Moreover, recent studiCategory
-
Peptide name
Catalogue
PPH08-0132Target
a-synuclein has been suggested to be implicated in the pathogenesis of Parkinson’s disease and related neurodegenerative disorders, and more recently, to be an important regulatory component of vesicular transport in neuronal cells. Moreover, recent studiCategory
-
Peptide name
Catalogue
PPH08-0126Target
a-synuclein has been suggested to be implicated in the pathogenesis of Parkinson’s disease and related neurodegenerative disorders, and more recently, to be an important regulatory component of vesicular transport in neuronal cells. Moreover, recent studiCategory
-
Peptide name
Catalogue
PPH08-0128Target
a-synuclein has been suggested to be implicated in the pathogenesis of Parkinson’s disease and related neurodegenerative disorders, and more recently, to be an important regulatory component of vesicular transport in neuronal cells. Moreover, recent studiCategory
-
Peptide name
Catalogue
PPH08-0127Target
a-synuclein has been suggested to be implicated in the pathogenesis of Parkinson’s disease and related neurodegenerative disorders, and more recently, to be an important regulatory component of vesicular transport in neuronal cells. Moreover, recent studiCategory
-
Peptide name
Catalogue
PPH08-0129Target
SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Four alternatively spliced transcripts encoding two different isoforms have been identified for this gene.Category
-
Peptide name
Catalogue
PPH08-0135Target
a-synuclein has been suggested to be implicated in the pathogenesis of Parkinson’s disease and related neurodegenerative disorders, and more recently, to be an important regulatory component of vesicular transport in neuronal cells. Moreover, recent studiCategory
-
Peptide name
Catalogue
PPH08-0130Target
a-synuclein has been suggested to be implicated in the pathogenesis of Parkinson’s disease and related neurodegenerative disorders, and more recently, to be an important regulatory component of vesicular transport in neuronal cells. Moreover, recent studiCategory
-
Peptide name
Catalogue
PPH08-0028Target
Blocker for Nicotinic Acetylcholine Receptor, A synthetic cone snail toxinCategory
-
Peptide name
Catalogue
PPH08-0029Target
Blocker for Nicotinic Acetylcholine Receptor in Central Nervous System, A synthetic cone snail toxinCategory
-
Peptide name
Catalogue
PPH08-0030Target
4 Blocker for Nicotinic Acetylcholine Receptor, A synthetic cone snail toxinCategory
-
Peptide name
Catalogue
PPH08-0031Target
Blocker for Nicotinic Acetylcholine Receptor, A synthetic cone snail toxinCategory
-
Peptide name
Catalogue
PPH08-0032Target
Antimicrobial Peptide / Chemoattractant for MonocytesCategory
-
Peptide name
Catalogue
PPH08-0033Target
Antimicrobial PeptideCategory
-
Peptide name
Catalogue
PPH08-0034Target
Antimicrobial PeptideCategory
-
Peptide name
Catalogue
PPH08-0117Target
Antimicrobial PeptideCategory
-
Peptide name
Catalogue
PPH08-0035Target
Antimicrobial Peptide in Paneth CellsCategory
-
Peptide name
Catalogue
PPH08-0118Target
Antimicrobial Peptide in Paneth CellsCategory
-
Peptide name
Catalogue
PPH08-0036Target
hypothalamic-hypophysial origin with morphinomimetic activityCategory
-
Peptide name
Catalogue
PPH08-0037Target
α-mating factor secretion signal, increased secretion of reporter proteins horseradish peroxidase and lipase at least 50% in small-scale cultures.Category
-
Catalogue
PPH08-0038Target
α-Melanocyte Stimulating HormoneCategory
-
Peptide name
Catalogue
PPH08-0039Target
Prodynorphin or Proenkephalin B is its precursor.Category
-
Peptide name
Catalogue
PPH08-0226Target
Fluorescent Tracer for Oligopeptide TransportersCategory
-
Peptide name
Catalogue
PPH08-0224Target
Antimicrobial Peptide. ELISA (EIA), Western Blot (WB)Category
-
Peptide name
Catalogue
PPH08-0220Target
Polypeptide Hormone; Produced by the Pituitary Gland in Response to Pain, Exercise, and Other Forms of StressCategory
-
Peptide name
Catalogue
PPH08-1044Target
Opioid peptideCategory
-
Peptide name
Catalogue
PPH08-0406Target
Synthetic Venom Libraries.Category
-
Peptide name
Catalogue
PPH08-0722Target
Na+ Channel Blocker: Specific for Skeletal Muscle, A synthetic cone snail toxinCategory
-
Peptide name
Catalogue
PPH08-0725Target
A synthetic cone snail toxin. Na+ Channel BlockerCategory
-
Peptide name
Catalogue
PPH08-0750Target
Tetrodotoxin-Resistant Na+ Channel Blocker with Analgesic Activity, A synthetic cone snail toxinCategory
-
Peptide name
Catalogue
PPH08-0835Target
P-type Ca2+ Channel Selective Blocker, A synthetic Funnel Web Spider toxinCategory
-
Peptide name
Catalogue
PPH08-0837Target
N-type Ca2+ Channel Blocker, A synthetic cone snail toxinCategory
-
Peptide name
Catalogue
PPH08-0838Target
Reversible N-type Ca2+ Channel Blocker, A synthetic cone snail toxinCategory